AlgiPharma has been awarded a four year grant from the Norwegian Research Council for the project “Tailored OligoG in the treatment of chronic infectious biofilms”. This study involving an international consortium will investigate microbial sources of raw material for AlgiPharma’s alginate technology and determine optimal oligomer length associated with specific known OligoG antimicrobial properties.
For further information, please contact:
Arne Dessen, Chairman of Board; email@example.com
Philip D. Rye R&D Director; firstname.lastname@example.org